Epilepsy and coronavirus (COVID-19) – FAQs

2nd April 2020

Since the outbreak of COVID-19, there have been a number of questions from the epilepsy community. Understandably, people want to know if having epilepsy is a factor that means they need to be extra cautious.  Of course, not everything is known about COVID-19 at this point, however, in this post, we’re going to try and…

Read more

Category: News

Acquired epilepsy

31st March 2020

Recently, we wrote a blog article on the genetic factors of epilepsy. We also mentioned that in many cases there are no genetic factors to epilepsy, which is known as acquired epilepsy.  Acquired epilepsy can be used to describe a number of causes that are not genetic in nature, this means they were not passed…

Read more

Category: Education

Panayiotopoulos syndrome

25th March 2020

At present, it is not known how common panayiotopoulos syndrome is, it’s estimated that it could affect as many as 1 in 10 children with epilepsy but could also be closer to 1 in 20. Panayiotopoulos syndrome usually presents in children between the ages of 3 and 5, but has also been known to affect…

Read more

Category: Syndromes

COVID-19 (Coronavirus) Statement – National Epilepsy Training

25th March 2020

We at National Epilepsy Training are working tirelessly to adapt our services in response to the COVID-19 coronavirus pandemic. Our first priority is to ensure that our staff and clients are safe and have the support that they need during this time and also to follow government guidance to slow the spread of the outbreak. …

Read more

Category: News

Graphene implant could be the key to new epilepsy treatments

18th March 2020

Researchers have developed a new graphene-based implant that could have a huge impact on the advancement of epilepsy treatments. The implant is able to monitor and record electrical activity within the brain at extremely low frequencies that were previously too low to monitor.  It’s this discovery that has unlocked new data, which is found below…

Read more

Category: News, Treatments

Could a drug-drug interaction explain the effectiveness of cannabidiol on severe forms of epilepsy?

13th March 2020

Cannabidiol has been big news in the epilepsy community over the last year. We have previously posted about the medication becoming available on the NHS for patients with certain syndromes and types of epilepsy. At present, researchers are unsure as to why cannabidiol has the positive effect that it does.  However, research reported in the…

Read more

Category: News, Treatments